Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
- Charles C Wykoff
- Charles C Wykoff
- Francis Abreu
- Anthony P Adamis
- Karen Basu
- David A Eichenbaum
- Zdenka Hašková
- Hugh Lin
- Anat Loewenstein
- Shaun Mohan
- Ian A Pearce
- Taiji Sakamoto
- Patricio G Schlottmann
- David G. Silverman
- Jennifer K Sun
- John A Wells
- Jeffrey R Willis
- Ramin Tadayoni
- Thomas Aaberg
- Ashkan Abbey
- Э А Абдулаева
- Santiago Abengoechea
- Prema Abraham
- Thomas Ach
- Serrhel Adams
- Alfredo Adan Civera
- Sean D. Adrean
- Hansjurgen Agostini
- Suhail Alam
- Arturo Alezzandrini
- Virgil Alfaro
- Daniel Aliseda
- Arghavan Almony
- Pedro Amat
- Payam Amini
- Andrew Antoszyk
- Luís Arias
- Riaz Asaria
- Marcos Avila
- Carl C Awh
- Joaquin Bafalluy
- Carl Baker
- Francesco Bandello
- Mark Barakat
- Karen Barraza
- Gyorgy Bator
- Caroline Baumal
- Rubens Belfort Jr
- Chris Bergstrom
- George Bertolucci
- Thomas Bochow
- Matthias Bolz
- Emilia Borcz
- Arnaldo Bordon
- David Boyer
- Galina Bratko
- Michael Brent
- Jamin Brown
- David M Brown
- Maria Budzinskaya
- Sylvia Buffet
- Stuart Burgess
- Ben Burton
- Miguel Busquets
- Francisco Cabrera
- Carlo Cagini
- Jorge Calzada
- Peter Campochiaro
- John Carlson
- Alessandro Castellarin
- Carlos Cava
- Voraporn Chaikitmongkol
- Clement Chan
- Emmanuel Chang
- Jonathan Chang
- Andrew Chang
- Steve Charles
- Nauman Chaudhry
- Caroline Chee
- Judy Chen
- Fred Chen
- Shih-Jen Chen
- Richard Cheong-Leen
- Allen Chiang
- Mark Chittum
- David Chow
- Brian Connolly
- Pierre Loic Cornut
- Karl Csaky
- Carl Danzig
- Arup Das
- Vesselin Daskalov
- Carmen Desco
- Amr Dessouki
- John Dickinson
- Brian Do
- Michael Dollin
- Pravin Dugel
- Jaroslava Dusova
- David Eichenbaum
- BSBerthold Seitz
The Lancet · 2022 · Elsevier BV
0 views · 0 downloads